The majority of clinical trials for testicular cancer are used to compare new therapies to existing ones. Through these trials, oncologists can find the most effective treatments, determine the optimum dosages, look for potential drug interactions and discover the best ways to help manage side effects. At the same time, patients can access the most innovative options in testicular cancer treatment, including new combinations of chemotherapy drugs and advanced surgical techniques. A smaller percentage of clinical trials are also used to investigate other testicular cancer-related topics. These include:
- Predictive factors (including genetic and environmental factors) that could help oncologists determine who is more at risk for developing the disease
- Diagnostic techniques and screening methods (such as biomarker-based blood tests) that can help increase the likelihood of early detection
- DNA mutations that cause the cancer to develop
At Moffitt Cancer Center, our clinical trials are supervised by a team of oncologists and researchers who follow each patient’s progress to ensure maximum safety and comfort. Patients are never required to participate in a clinical trial, and those who do may stop at any time. Most importantly, because our multispecialty tumor board meets weekly to review each patient’s progress, we can make individualized adjustments as necessary to ensure the best possible outcome and quality of life.
Moffitt emphasizes research because we believe that every clinical trial gets us one step closer to a cure – and we won’t be satisfied until there is one. Because of our research efforts, we have been named a Comprehensive Cancer Center by the National Cancer Institute – the only such center based in Florida. To learn more about our clinical trials for testicular cancer, call 1-813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form online.